FDA
approval
· 2023-12-18
FDA Approved: HYDROCODONE BITARTRATE AND IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
Summary
FDA approved a supplemental application for HYDROCODONE BITARTRATE AND IBUPROFEN (Amneal Pharmaceuticals of New York LLC), authorizing its marketing as a combin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE AND IBUPROFEN)